medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2006, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2006; 4 (2)

Sézary cell: Its evolution as a concept and as a diagnostic rule in cutaneous lymphoma

Narváez RV, Ponce ORM

Language: Spanish
References: 17
Page: 105-108
PDF size: 322.68 Kb.


ABSTRACT

Sézary cells (mycosis cell, Lutzner cell, cerebriform lymphocytes or monster cell) are atypical lymphocytes with a cerebriform nucleus in both tissue and blood, seen in cutaneous T cell lymphomas including mycosis fungoides and Sézary syndrome, but they are also present in other skin diseases. Nowadays, inmunophenotypical analyses are trying to identificate different markers in these cells in the early diagnosis of some cutaneous lymphomas.


REFERENCES

  1. Russell-Jones J. Diagnosing erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 2005; 153: 1-5

  2. Santucci M, Biggeri A, Feller A. Efficacy of Histologic Criteria for Diagnosing Early Mycosis Fungoides: An EORTC investigation. Am J Sur Pathol 2001; 24 (1): 40

  3. Liu V, McKee P. Cutaneous T-Cell Lymphoproliferative Disorders Approach for Surgical Pathologist: Recent Advances and Clarification of Confused Issues. Adv Anat Pathol 2002; 9 (2): 79-100 Volumen 4 / Número 2 / abril-junio 2006 Dermatología Cosmética, Médica y Quirúrgica 107 Verónica Narváez y Rosa María Ponce Célula de Sézary Figura 2. Acercamiento de célula de Sézary; el núcleo ocupa 4/5 de la célula y posee identaciones estrechas.

  4. Slater D. The new World Health Organization classification of haemotopoietic and lymphoid tumours: A dermatopathological perspective. Br J Dermatol 2002; 147: 633-639

  5. Kim Y, Liu H, Mraz-Gernhard S et al. Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome Clinical prognostic Factors and Risk for Disease progression. Arch Dermatol 2003; 139: 857-866

  6. Bernengo M, Novelli M, Quaglino P et al. The prevalence of the CD4+ CD26– subset in the identification of circulating Sézary cells. Br J Dermatol 2001; 144: 125-135

  7. Girardi M, Heald P, Wilson L. The Pathogenesis of Mycosis Fungoides. N Eng J Med 2004; 350: 1978-1988

  8. Cyriac MJ, Kurian A. Sezary Cell. In J Dermatol, Venereol, Leprol 2004; 70 (5): 321-324

  9. Winkelman K, Buechner S, Díaz-Pérez J. Pre-Sézary Syndrome. J Am Acad Dermatol 1984; 10 (6): 992-999

  10. Foulc P, Guyen J, Drenó B. Prognostic factors in Sézary syndrome; a study of 28 patients. Br J Dermatol 2003; 149: 1152-1158

  11. Vonderheid E, Bernengo M, Burg G. Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46: 95-106

  12. Weinberg M, Jaworsky C, Benoit B et al. The Clonal Nature of Circulating Sézary Cells. Blood 1995; 86 (11): 4257-4262

  13. Winkelmann R. History of the Sézary Syndrome. Mayo Clin Proc 1974; 49: 515-518

  14. Prunieras M. DNA Content and Cytogenetics of the Sézary Cell. Mayo Clin Proc 1974; 49: 548-552

  15. Winkelman R, Szasz M. Absolute Number of Circulating Sézary Cells. Arch Dermatol 1981; 117: 382

  16. Kim L, Hess S, Richardson S et al. Immunopathogenesis and therapy of cutaneous T cell Lymphoma. J Clin Invest 2005; 115: 798-812

  17. Meijer C, Van Der Loo E, Vloten W et al. Early Diagnosis of Mycosis Fungoides and Sézary’s Syndrome by Morphometric Analysis of Lymphoid Cells in the Skin. Cancer 1980; 45: 2864-2871




2020     |     www.medigraphic.com